Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022)

Agios Pharmaceuticals (AGIO) posted Capital Leases of $276000.0 for Q1 2022, little changed on a QoQ basis from $276000.0 in Q4 2021, and up 11.29% year-over-year from $248000.0 in Q1 2021.

Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022) Analysis & Trends

Agios Pharmaceuticals' Capital Leases history runs 4 years deep, the most recent figure standing at $276000.0 for Q1 2022.

  • Quarterly Capital Leases rose 11.29% year-over-year to $276000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $276000.0 (up 11.29% YoY) and the FY2021 annual result came in at $276000.0, down 16.62% from the prior year.
  • Capital Leases was $276000.0 for Q1 2022 at Agios Pharmaceuticals, roughly flat from $276000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $673000.0 in Q4 2019 and bottomed at $167000.0 in Q2 2021.
  • A 4-year average of $340428.6 and a median of $276000.0 in 2021 frame the typical range for Capital Leases.
  • Annual changes were most pronounced in 2020 — Capital Leases slumped 50.82% — and 2022, when it grew 11.29%.
  • Agios Pharmaceuticals' Capital Leases stood at $673000.0 in 2019, then slumped by 50.82% to $331000.0 in 2020, then retreated by 16.62% to $276000.0 in 2021, then changed by 0.0% to $276000.0 in 2022.
  • Business Quant data shows AGIO's Capital Leases at $276000.0 in Q1 2022, $276000.0 in Q4 2021, and $167000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Agios Pharmaceuticals 2.13 Bn 2.13 Bn 19.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 276,000.00
Dec 31, 2021 276,000.00
Jun 30, 2021 167,000.00
Mar 31, 2021 248,000.00
Dec 31, 2020 331,000.00
Sep 30, 2020 412,000.00
Dec 31, 2019 673,000.00